Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Journal of Neuroscience Research
|
September 19, 2012
Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease
Guoxin Wu, Sethu Sankaranarayanan, Jacky Wong, et al.
Acta Neuropathologica Communications
|
March 4, 2016
C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy
Rhona McGonigal, Madeleine E Cunningham, Denggao Yao, et al.
Clinical Biochemistry
|
May 21, 2008
Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects
Guoxin Wu, Sethu Sankaranarayanan, Kate Tugusheva, et al.
Investigative Ophthalmology & Visual Science
|
February 2, 2023
Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates
Anita Grover, Sethu Sankaranarayanan, Vidhu Mathur, et al.
Archives of Neurology
|
August 13, 2008
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
Henrik Zetterberg, Ulf Andreasson, Oskar Hansson, et al.
Clinical Pharmacology in Drug Development
|
May 16, 2023
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5
Nicholas P France, Christopher Rubino, M Courtney Safir, et al.
Plos One
|
October 12, 2013
Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease
Jere E Meredith, Sethu Sankaranarayanan, Valerie Guss, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 1, 2015
Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice
Deepak R Thakker, Sethu Sankaranarayanan, Marcy R Weatherspoon, et al.
NPJ Parkinson'S Disease
|
October 25, 2024
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants
Stefanie Lerche, Isabel Wurster, Enza Maria Valente, et al.
Journal of Alzheimer'S Disease : JAD
|
March 23, 2011
Tau transgenic mice as models for cerebrospinal fluid tau biomarkers
Donna M Barten, Gregory W Cadelina, Nina Hoque, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Journal of Neuroscience Research
|
September 19, 2012
Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease
Guoxin Wu, Sethu Sankaranarayanan, Jacky Wong, et al.
Acta Neuropathologica Communications
|
March 4, 2016
C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy
Rhona McGonigal, Madeleine E Cunningham, Denggao Yao, et al.
Clinical Biochemistry
|
May 21, 2008
Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects
Guoxin Wu, Sethu Sankaranarayanan, Kate Tugusheva, et al.
Investigative Ophthalmology & Visual Science
|
February 2, 2023
Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates
Anita Grover, Sethu Sankaranarayanan, Vidhu Mathur, et al.
Archives of Neurology
|
August 13, 2008
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
Henrik Zetterberg, Ulf Andreasson, Oskar Hansson, et al.
Clinical Pharmacology in Drug Development
|
May 16, 2023
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5
Nicholas P France, Christopher Rubino, M Courtney Safir, et al.
Plos One
|
October 12, 2013
Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease
Jere E Meredith, Sethu Sankaranarayanan, Valerie Guss, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 1, 2015
Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice
Deepak R Thakker, Sethu Sankaranarayanan, Marcy R Weatherspoon, et al.
NPJ Parkinson'S Disease
|
October 25, 2024
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants
Stefanie Lerche, Isabel Wurster, Enza Maria Valente, et al.
Journal of Alzheimer'S Disease : JAD
|
March 23, 2011
Tau transgenic mice as models for cerebrospinal fluid tau biomarkers
Donna M Barten, Gregory W Cadelina, Nina Hoque, et al.
Page
of 4